Thomas K Equels - 12 Jun 2025 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Signature
/s/ Thomas K Equels
Issuer symbol
AIMI
Transactions as of
12 Jun 2025
Net transactions value
+$824
Form type
4
Filing time
16 Jun 2025, 10:53:28 UTC
Previous filing
23 Apr 2025
Next filing
10 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Equels Thomas K CEO & President, Director 2117 SOUTHWEST HIGHWAY 484, OCALA /s/ Thomas K Equels 16 Jun 2025 0001450324

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIM Common Stock Purchase $824 +107 +0.28% $7.70* 38,885 13 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.